Skip to content
Disclosery

TANG CAPITAL MANAGEMENT LLC

Follow

13F filer, CIK 1232621, SAN DIEGO, CA

TANG CAPITAL MANAGEMENT LLC reported $1,968,963,283 across 51 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-15. Its ten largest share positions make up 57.9% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001214659-26-006493

Period
2026-03-31
Reported value
$1.97B
Holdings
51
Top 10 weight
57.9%
New
4
Sold out
28

Part of the filer group TANG CAPITAL MANAGEMENT LLC

  • TANG KEVIN
  • TANG CAPITAL PARTNERS III, INC
  • TANG CAPITAL PARTNERS INTERNATIONAL, LP
  • TANG CAPITAL PARTNERS IV, INC
  • TANG CAPITAL PARTNERS, LP
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPYadded+138,000$89.7M
CORTadded+1,343,236$54.1M
CAPRadded+1,699,900$51.7M
INSMadded+200,000$32.7M
CMPSnew+4,002,200$22.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RNAMexited-900,000-$64.9M
VRTXexited-80,000-$36.3M
MRNAreduced-592,820-$30.1M
TVTXexited-700,000-$26.7M
VTYXexited-2,814,000-$25.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001214659-26-006493, largest first. % of portfolio is the value over $1,968,963,283, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,229,500 shares; 2024Q4: 8,429,500 shares; 2025Q1: 10,029,500 shares; 2025Q2: 10,029,500 shares; 2025Q3: 11,329,500 shares; 2025Q4: 11,329,500 shares; 2026Q1: 12,229,500 shares 12,229,500$181M9.2%+900,000Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,150,000 shares; 2025Q4: 1,050,000 shares; 2026Q1: 1,050,000 shares 1,050,000$120M6.09%0Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,287,107 shares; 2024Q4: 1,237,107 shares; 2025Q1: 1,237,107 shares; 2025Q2: 1,236,027 shares; 2025Q3: 1,236,027 shares; 2025Q4: 1,236,027 shares; 2026Q1: 1,236,027 shares 1,236,027$114M5.8%0Timeline
LKFTLAKEFRONT BIOTHERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 700,000 shares; 2024Q4: 2,161,200 shares; 2025Q1: 3,961,797 shares; 2025Q2: 3,990,111 shares; 2025Q3: 4,151,194 shares; 2025Q4: 3,921,219 shares; 2026Q1: 3,785,991 shares 3,785,991$114M5.77%-135,228Timeline
SPYSTATE STR SPDR S&P 500 ETF TQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 168,000 shares 168,000$109M5.55%+138,000Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 628,609 shares; 2024Q4: 628,609 shares; 2025Q1: 2,118,579 shares; 2025Q2: 2,328,609 shares; 2025Q3: 2,328,609 shares; 2025Q4: 2,259,889 shares; 2026Q1: 2,259,889 shares 2,259,889$109M5.53%0Timeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 79,100 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,700,000 shares; 2026Q1: 3,399,900 shares 3,399,900$103M5.25%+1,699,900Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 700,000 shares; 2024Q4: 700,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,100,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 1,500,000 shares; 2026Q1: 1,500,000 shares 1,500,000$102M5.19%0Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,050,000 shares; 2025Q2: 3,200,000 shares; 2025Q3: 3,200,000 shares; 2025Q4: 1,892,200 shares; 2026Q1: 1,892,200 shares 1,892,200$95.4M4.85%0Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,321,547 shares; 2024Q4: 4,893,847 shares; 2025Q1: 4,941,798 shares; 2025Q2: 4,941,798 shares; 2025Q3: 5,041,798 shares; 2025Q4: 4,573,530 shares; 2026Q1: 4,573,530 shares 4,573,530$92.1M4.68%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,812,995 shares; 2024Q4: 5,900,000 shares; 2025Q1: 11,052,632 shares; 2025Q2: 13,496,208 shares; 2025Q3: 16,811,963 shares; 2025Q4: 16,790,809 shares; 2026Q1: 16,790,809 shares 16,790,809$88.8M4.51%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,254,797 shares; 2024Q4: 2,254,797 shares; 2025Q1: 2,454,797 shares; 2025Q2: 2,454,797 shares; 2025Q3: 2,454,797 shares; 2025Q4: 1,188,624 shares; 2026Q1: 1,188,624 shares 1,188,624$83.4M4.23%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,105,600 shares; 2024Q4: 1,555,600 shares; 2025Q1: 1,915,708 shares; 2025Q2: 2,105,608 shares; 2025Q3: 2,305,608 shares; 2025Q4: 2,628,538 shares; 2026Q1: 2,649,368 shares 2,649,368$79.9M4.06%+20,830Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,330,879 shares; 2024Q4: 1,330,879 shares; 2025Q1: 1,545,153 shares; 2025Q2: 1,330,879 shares; 2025Q3: 1,333,639 shares; 2025Q4: 1,332,087 shares; 2026Q1: 1,330,879 shares 1,330,879$73.8M3.75%-1,208Timeline
CORTCORCEPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 156,764 shares; 2026Q1: 1,500,000 shares 1,500,000$60.5M3.07%+1,343,236Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 450,000 shares; 2024Q4: 317,500 shares; 2025Q1: 317,500 shares; 2025Q2: 317,500 shares; 2025Q3: 317,500 shares; 2025Q4: 481,437 shares; 2026Q1: 707,500 shares 707,500$54.4M2.76%+226,063Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 100,000 shares; 2024Q4: 100,000 shares; 2025Q1: 100,000 shares; 2025Q2: 200,000 shares; 2025Q3: 200,000 shares; 2025Q4: 60,000 shares; 2026Q1: 260,000 shares 260,000$42.5M2.16%+200,000Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 270,000 shares; 2024Q4: 270,000 shares; 2025Q1: 270,000 shares; 2025Q2: 270,000 shares; 2025Q3: 270,000 shares; 2025Q4: 470,000 shares; 2026Q1: 470,000 shares 470,000$41.8M2.12%0Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,242,925 shares; 2024Q4: 2,492,925 shares; 2025Q1: 2,792,925 shares; 2025Q2: 2,842,925 shares; 2025Q3: 2,842,925 shares; 2025Q4: 1,792,626 shares; 2026Q1: 1,792,626 shares 1,792,626$35.1M1.78%0Timeline
AVIRATEA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,607,060 shares; 2024Q4: 4,788,912 shares; 2025Q1: 4,800,000 shares; 2025Q2: 4,889,200 shares; 2025Q3: 4,826,200 shares; 2025Q4: 4,814,700 shares; 2026Q1: 4,814,700 shares 4,814,700$25.9M1.32%02026-10-06, 13G: 4,814,700 shares, 6% of the class, 13G filed 2026-10-06 Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 500,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 12,400,000 shares; 2025Q4: 5,617,500 shares; 2026Q1: 6,417,500 shares 6,417,500$24.8M1.26%+800,000Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 264,692 shares; 2024Q4: 264,692 shares; 2025Q1: 264,692 shares; 2025Q2: 264,692 shares; 2025Q3: 264,692 shares; 2025Q4: 264,692 shares; 2026Q1: 264,692 shares 264,692$22.2M1.13%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,000,000 shares; 2025Q1: 1,400,000 shares; 2025Q2: 1,300,000 shares; 2025Q3: 2,200,000 shares; 2025Q4: not reported; 2026Q1: 4,002,200 shares 4,002,200$22.1M1.12%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,152 shares; 2025Q3: 679,824 shares; 2025Q4: 872,398 shares; 2026Q1: 1,160,000 shares 1,160,000$21.3M1.08%+287,602Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 300,000 shares; 2025Q1: 500,000 shares; 2025Q2: 500,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares 500,000$16.3M0.83%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 120,000 shares; 2024Q4: 320,000 shares; 2025Q1: 270,000 shares; 2025Q2: 370,000 shares; 2025Q3: 870,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares 500,000$16.3M0.83%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares; 2025Q4: 450,000 shares; 2026Q1: 450,000 shares 450,000$15M0.76%0Timeline
NUVBNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,900,000 shares; 2024Q4: 3,900,000 shares; 2025Q1: 3,900,000 shares; 2025Q2: 3,900,000 shares; 2025Q3: 4,200,000 shares; 2025Q4: 3,857,457 shares; 2026Q1: 3,149,557 shares 3,149,557$13.5M0.69%-707,900Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 6,000,000 shares; 2025Q2: 6,000,000 shares; 2025Q3: 6,003,446 shares; 2025Q4: 6,143,132 shares; 2026Q1: 6,143,132 shares 6,143,132$7.74M0.39%0Timeline
DERMJOURNEY MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,725,569 shares; 2025Q1: 1,854,596 shares; 2025Q2: 1,854,596 shares; 2025Q3: 1,854,596 shares; 2025Q4: 1,854,596 shares; 2026Q1: 1,610,000 shares 1,610,000$7.55M0.38%-244,596Timeline
JANXJANUX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 50,000 shares; 2025Q1: 150,000 shares; 2025Q2: 200,000 shares; 2025Q3: 700,000 shares; 2025Q4: not reported; 2026Q1: 500,000 shares 500,000$6.95M0.35%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 35,000 shares; 2025Q2: 35,000 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares 35,000$6.42M0.33%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,000,000 shares; 2025Q3: 1,000,000 shares; 2025Q4: 350,000 shares; 2026Q1: 350,000 shares 350,000$6.29M0.32%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 180,000 shares; 2024Q4: not reported; 2025Q1: 1,393,800 shares; 2025Q2: 1,393,800 shares; 2025Q3: 1,393,800 shares; 2025Q4: 569,698 shares; 2026Q1: 538,658 shares 538,658$5.71M0.29%-31,040Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,785,201 shares; 2025Q4: 4,940,000 shares; 2026Q1: 4,245,085 shares 4,245,085$5.26M0.27%-694,915Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 300,000 shares; 2025Q1: 305,300 shares; 2025Q2: 305,300 shares; 2025Q3: 305,300 shares; 2025Q4: 692,820 shares; 2026Q1: 100,000 shares 100,000$5.08M0.26%-592,820Timeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,850,000 shares; 2024Q4: 2,140,271 shares; 2025Q1: 2,235,459 shares; 2025Q2: 2,135,459 shares; 2025Q3: 3,450,000 shares; 2025Q4: 6,250,000 shares; 2026Q1: 6,250,000 shares 6,250,000$5M0.25%0Timeline
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 720,000 shares; 2025Q1: 720,000 shares; 2025Q2: 720,000 shares; 2025Q3: 720,000 shares; 2025Q4: 664,314 shares; 2026Q1: 664,314 shares 664,314$4.93M0.25%0Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 600,000 shares; 2026Q1: 600,000 shares 600,000$4.35M0.22%0Timeline
LENZLENZ THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 766,940 shares; 2024Q4: 766,940 shares; 2025Q1: 766,940 shares; 2025Q2: 897,616 shares; 2025Q3: 897,616 shares; 2025Q4: 865,169 shares; 2026Q1: 451,114 shares 451,114$4.13M0.21%-414,055Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares 100,000$3.38M0.17%newTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 502,915 shares; 2024Q4: 602,915 shares; 2025Q1: 1,190,012 shares; 2025Q2: 1,502,915 shares; 2025Q3: 1,502,915 shares; 2025Q4: 900,000 shares; 2026Q1: 200,000 shares 200,000$3.24M0.16%-700,000Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,350,000 shares; 2024Q4: 3,650,000 shares; 2025Q1: 5,097,362 shares; 2025Q2: 5,097,362 shares; 2025Q3: 5,097,362 shares; 2025Q4: 2,724,509 shares; 2026Q1: 1,886,748 shares 1,886,748$3.19M0.16%-837,761Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 650,000 shares; 2024Q4: 2,293,719 shares; 2025Q1: 7,055,576 shares; 2025Q2: 7,055,576 shares; 2025Q3: 7,055,576 shares; 2025Q4: 1,480,823 shares; 2026Q1: 1,480,823 shares 1,480,823$3.12M0.16%0Timeline
ALTALTIMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,750,000 shares; 2024Q4: 2,750,000 shares; 2025Q1: 2,750,000 shares; 2025Q2: 2,750,000 shares; 2025Q3: 2,131,307 shares; 2025Q4: 2,131,307 shares; 2026Q1: 666,022 shares 666,022$2.05M0.1%-1,465,285Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,847,399 shares; 2024Q4: 4,997,399 shares; 2025Q1: 4,997,399 shares; 2025Q2: 4,997,399 shares; 2025Q3: 5,488,299 shares; 2025Q4: 1,245,692 shares; 2026Q1: 483,021 shares 483,021$1.99M0.1%-762,671Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,000,000 shares; 2026Q1: 400,000 shares 400,000$1.79M0.09%-600,000Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 700,000 shares; 2024Q4: 1,855,954 shares; 2025Q1: 1,867,773 shares; 2025Q2: 1,867,773 shares; 2025Q3: 1,867,773 shares; 2025Q4: 1,167,773 shares; 2026Q1: 1,167,773 shares 1,167,773$1.4M0.07%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,400,000 shares; 2025Q2: 1,400,000 shares; 2025Q3: 1,400,000 shares; 2025Q4: 967,235 shares; 2026Q1: 439,878 shares 439,878$858K0.04%-527,357Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 100,000 shares; 2024Q4: 850,268 shares; 2025Q1: 1,150,268 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 399,700 shares 399,700$624K0.03%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 750,000 shares; 2024Q4: 750,000 shares; 2025Q1: 850,000 shares; 2025Q2: 850,000 shares; 2025Q3: 850,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares 100,000$358K0.02%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RNAMAVIDITY BIOSCIENCES INC900,000$64.9Mshares
VRTXVERTEX PHARMACEUTICALS INC80,000$36.3Mshares
TVTXTRAVERE THERAPEUTICS INC700,000$26.7Mshares
VTYXVENTYX BIOSCIENCES INC2,814,000$25.4Mshares
NVDANVIDIA CORPORATION127,788$23.8Mshares
METAMETA PLATFORMS INC23,331$15.4Mshares
GSKGSK PLC300,000$14.7Mshares
PCVXVAXCYTE INC275,000$12.7Mshares
HRMYHARMONY BIOSCIENCES HLDGS IN290,292$10.9Mshares
BMYBRISTOL-MYERS SQUIBB CO200,000$10.8Mshares
TDOCTELADOC HEALTH INC1,400,000$9.8Mshares
DVAXDYNAVAX TECHNOLOGIES CORP556,359$8.56Mshares
VSTMVERASTEM INC1,069,810$8.26Mshares
ACADACADIA PHARMACEUTICALS INC300,000$8.01Mshares
SRPTSAREPTA THERAPEUTICS INC349,220$7.52Mshares
TBPHTHERAVANCE BIOPHARMA INC351,252$6.57Mshares
BCRXBIOCRYST PHARMACEUTICALS INC800,000$6.24Mshares
REGNREGENERON PHARMACEUTICALS8,000$6.17Mshares
IBRXIMMUNITYBIO INC2,333,333$4.62Mshares
NUVLNUVALENT INC21,880$2.2Mshares
AREALEXANDRIA REAL ESTATE EQ IN40,000$1.96Mshares
STROSUTRO BIOPHARMA INC139,617$1.62Mshares
BHVNBIOHAVEN LTD140,000$1.58Mshares
RVMDREVOLUTION MEDICINES INC15,640$1.25Mshares
ZYMEZYMEWORKS INC34,631$912Kshares
ACETADICET BIO INC6,158$51.9Kshares
TCRXTSCAN THERAPEUTICS INC46,131$46.1Kshares
FLNAFILANA THERAPEUTICS INC7,073$14Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001214659-26-006493 base2026-05-15acceptance time not in the bulk data set